BCL11B activated T-ALL/LBL is a new genetic subtype recognized by the ICC, which encompasses ~ 30% of ETP ALL and is driven mostly by BCL11B rearrangements (Table 12). Here, BCL11B is linked to acute lymphoblastic leukemia.